“Integration of Advanced Analytical Technologies and Automation”
- A key trend in the global therapeutic drug monitoring market is the increasing integration of advanced analytical technologies and automation in diagnostic workflows
- Techniques such as liquid chromatography–mass spectrometry (LC-MS), immunoassays, and high-throughput analyzers are enhancing the speed, sensitivity, and accuracy of drug level detection in patient samples
- For instance, automated LC-MS platforms are increasingly being adopted in clinical laboratories for their ability to provide rapid and precise quantification of multiple drugs, especially in complex treatment regimens such as oncology or transplant care
- Automation also supports large-scale drug monitoring programs by reducing manual errors, streamlining lab operations, and enabling faster decision-making for individualized treatment adjustments
- This trend is transforming therapeutic drug monitoring into a more efficient, data-driven process, driving its adoption across hospitals, clinics, and diagnostic labs globally
